India · English
Rossari Biotech Q2 Revenue ₹697.6 Crore, Up 19%; EBITDA ₹87 Crore, A 20.9% Rise
Mumbai: Rossari Biotech Limited , a specialty chemicals manufacturer, announced its unaudited financial results for the quarter and half-year ended 30 September 2026. The company reported a consolidated revenue of ₹697.6 crore for the second quarter of fiscal year 2027, marking a 19% growth year-on-year. Rossari Biotech Q1 Profit Rises To ₹47 Crore, Revenue Up 28% Financial Performance…
Read the full report at Free Press Journal →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.